MDM2 enhances the function of estrogen receptor in human breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 281, Issue 1, 2001, Pages 259-265

  Saji, Shigehira ^a,b   Okumura, Naoki ^a,b   Eguchi, Hidetaka ^a   Nakashima, Shigeru ^b   Suzuki, Akio ^c   Toi, Masakazu ^c   Nozawa, Yoshinori ^b   Saji, Shigetoyo ^b   Hayashi, Shin ichi ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Breast cancer; Estrogen receptor; MCF 7; MDM2; P53

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53;

ARTICLE; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; WESTERN BLOTTING;

MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0034810227     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4339     Document Type: Article

References (46)

1. Amplification of a gene encoding a p53-associated protein in human sarcomas
2. MDM2 gene amplification in human breast cancer
3. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status
4. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
5. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
6. The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger
7. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
8. Mdm2 promotes the rapid degradation of p53
9. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
10. Regulation of p53 stability by Mdm2
11. mdm2 expression is induced by wild type p53 activity
12. Interaction between the retinoblastoma protein and the oncoprotein MDM2
13. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein
14. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes
15. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain
16. Amplification of MDM2 inhibits MyoD-mediated myogenesis
17. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
18. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
19. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
20. The steroid and thyroid hormone receptor superfamily
21. Cloning of a novel receptor expressed in rat prostate and ovary
22. Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer
23. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. A univarlate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on Hormone Receptors and Prognosis in Breast Cancer
24. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator
25. mdm2 gene alterations and mdm2 protein expression in breast carcinomas
26. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells
27. MDM2 overexpression in benign and malignant lesions of the human breast: Association with ER expression
28. The expression of MDM2 and p53 protein in breast carcinoma
29. Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma
30. Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol
31. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
32. Modulation of cell proliferation and gene expression by a p53-estrogen receptor hybrid protein
33. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: Studies using human estrogen receptor overexpressed in mammalian cells
34. Expression of wild-type estrogen receptor β and variant isoforms in human breast cancer
35. The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways
36. Estrogen receptor protects p53 from deactivation by human double minute-2
37. Nuclear receptor coactivators and corepressors
38. Enhanced translation: A novel mechanism of mdm2 oncogene overexpression identified in human tumor cells
39. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein
40. Nuclear receptor coactivators
41. p300 is a component of an estrogen receptor coactivator complex
42. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
43. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
44. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
45. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
46. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily